Familial multiple lipomatosis is a genetic disorder characterized by the formation of multiple lipomas, benign tumors made up of fatty tissue. These tumors can develop in various parts of the body, including the arms and legs, back, neck, and abdomen. Lipomas are usually painless and slow-growing, but in some patients they can cause discomfort or limit mobility depending on their location. The disease tends to run in families, making it especially predisposing in families with multiple lipomas.
History of the disease and interesting historical facts
Familial multiple lipomatosis has been studied for many decades, but its full pathogenesis remains unclear. The first recorded cases of this disease date back to the early 20th century, when doctors began to classify various forms of lipomas and their hereditary nature. In 1936, Swiss dermatologist Albert Benjamin first described the familial type of lipomatosis, isolating it as a separate nosological unit. It is interesting to note that in some cultures, the presence of multiple lipomas is sometimes considered a sign of “fatty well-being,” which is practically contrary to the medical and aesthetic principles of this condition.
Epidemiology
According to current epidemiological data, familial multiple lipomatosis occurs in approximately 1 in 100,000 people. Signs and symptoms may vary depending on age and heredity. The most pronounced predisposition is observed in people of European descent, while in African and Asian populations the disease is recorded much less frequently. However, the full picture of prevalence remains unclear due to a lack of data on cases in different countries and cultures.
Genetic predisposition to this disease
Studies have shown that familial multiple lipomatosis has a genetic predisposition associated with mutations in genes such as **LPP** and **ADGRG6**. These genes are involved in cell adhesion and migration, which may be associated with the formation of lipomas. Familial inheritance of this disease is due to the autosomal dominant type of transmission, which means that only one allele is enough to develop symptoms. Scientific studies have identified various mutations and their association with phenotypic manifestations, which highlights the complexity of the genetic aspect of the disease.
Risk factors for the development of this disease
Despite the predisposition to the disease, certain factors can influence its development. The main risk factors include:
- Heredity: presence of cases in family history.
- Age: the disease most often occurs in people aged 30-50 years.
- Gender: More common in males.
- Lifestyle: lack of physical activity and sedentary lifestyle.
- Obesity: Being overweight can contribute to the formation of lipomas.
Diagnosis of this disease
Diagnosis of familial multiple lipomatosis is made based on clinical examination and additional testing. The main symptoms include multiple, easily movable, soft masses under the skin. Laboratory tests, such as genetic testing, can confirm the presence of mutations associated with the disease. Radiological tests, including ultrasound and magnetic resonance imaging, can be used to evaluate the size and location of lipomas and to rule out malignancy. Differential diagnosis includes ruling out other tumor-like masses, such as fibromas and liposarcomas.
Treatment
Treatment of familial multiple lipomatosis may vary depending on the severity of symptoms and the number of lipomas. The main method is to observe the tumors if they do not cause discomfort. If there are signs of inflammation or cosmetic problems, surgery may be suggested. Pharmacological treatment is usually ineffective, but nonsteroidal anti-inflammatory drugs may be used for symptomatic relief. In some cases, corticosteroid injections may be used to reduce the size of the lipomas.
List of medications used to treat this disease
The most common medications used for symptomatic treatment and management of patients with familial multiple lipomatosis include:
- Nonsteroidal anti-inflammatory drugs (eg, Ibuprofen)
- Corticosteroids (by injection).
- Medicines that reduce the severity of symptoms: vitamins and minerals.
Disease monitoring
Monitoring of patients with familial multiple lipomatosis includes regular follow-up examinations as well as the use of radiological techniques to track changes in the lipomas. The prognosis for most patients is generally good, as lipomas are benign. However, complications related to their location, such as compression of adjacent anatomical structures and pain, may occur.
Age-related features of the disease
Familial multiple lipomatosis may manifest itself in different age groups with varying intensity. In children and adolescents, the disease usually manifests itself less actively, while in mature people, a more pronounced number of formations and possible functional disorders are observed. In elderly patients, changes in inflammatory processes are possible, which may require a more active interdisciplinary approach to treatment.
Questions and Answers
- What is familial multiple lipomatosis? It is a genetic disorder characterized by the formation of numerous benign fatty tumors.
- Is familial multiple lipomatosis inherited? Yes, the disease is hereditary and is usually transmitted in an autosomal dominant manner.
- What are the symptoms of the disease? The main symptoms are the presence of multiple soft formations under the skin, which can cause discomfort.
- How is the treatment carried out? Treatment may include observation, surgery, and limited use of medications.
- What is the prognosis for patients with this disease? The prognosis is usually favorable, since lipomas are benign formations.
Advice from Dr. Oleg Korzhikov
For patients suffering from familial multiple lipomatosis, it is important to remember the following:
- See a dermatologist or surgeon regularly to monitor the condition of your lipomas.
- If you notice any increase in the size of the tumors or the appearance of new growths, consult a doctor immediately.
- Monitor your lifestyle: Eating well and being physically active can reduce the risk of flare-ups.
